Evaluation of Nutritional Status in Hospitalized Chronic Obstructive Pulmonary Disease Patients and Can C-reactive Protein-to-Albumin Ratio Be Used in the Nutritional Risk Assessment in These Patients

被引:12
|
作者
Baldemir, Ramazan [1 ]
Ozturk, Ayperi [2 ]
Doganay, Guler Eraslan [3 ]
Cirik, Mustafa Ozgur [3 ]
Alagoz, Ali [1 ]
机构
[1] Ankara Ataturk Chest Dis & Thorac Surg Training, Anesthesiol & Reanimat, Ankara, Turkey
[2] Ankara Ataturk Chest Dis & Thorac Surg Training, Chest Dis, Ankara, Turkey
[3] Ankara Ataturk Chest Dis & Thorac Surg Training &, Anesthesiol & Reanimat, Ankara, Turkey
关键词
nutritional risk score-2002; nutrition; c-reactive protein-to-albumin ratio; c-reactive protein; chronic obstructive pulmonary disease; albumin; DIAGNOSTIC-CRITERIA; MALNUTRITION; PREVALENCE; COPD;
D O I
10.7759/cureus.21833
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Malnutrition is common in patients diagnosed with chronic obstructive pulmonary disease (COPD). CRP/albumin ratio (CAR) can be used as a parameter to evaluate the inflammatory process and nutritional status together. The aim of this study was to make a general evaluation of the nutritional status of hospitalized patients with COPD and to investigate whether CAR can predict nutritional status in these patients. Methods Patients who were hospitalized with COPD who were consulted to the nutrition department were included in the study. The patients' Nutritional Risk Score-2002 (NRS), demographic data, diagnoses, body mass indexes (BMI), nutritional support applied to the patients were recorded. CRP, Albumin, and CAR values of the patients were determined. Patients recommended nutritional follow-up, total parenteral nutrition (TPN) or enteral nutrition (EN) initiated, and oral nutritional supplement (ONS) support were identified. Results A total of 393 patients with COPD were analyzed. 88.55% of the patients were in the NRS) 3 risk group. TPN treatment was started in 10.2% of the patients, EN in 10.9%, ONS in 76.3%, and nutritional follow-up was recommended in 2.5% of the patients. While albumin level was lower in patients with NRS >= 3, CRP and CAR were higher in patients with NRS >= 3 (p < 0.05). There was a negative correlation between NRS-2002 and albumin (p < 0.001). A positive correlation was observed between NRS-2002 and CRP and CAR (p < 0.001). Age and CAR were found to be effective in predicting those with NRS-2002 >= 3. The cut-off value for CAR was accepted as 3.26. Conclusions The need for nutritional support is high in patients hospitalized with COPD. It is important to evaluate nutritional support needs in these patients, regardless of NRS-2002 and BMI. In this respect, the clinician's observation and the decision are as valuable as the scoring that determines malnutrition. We think that the cut-off value of 3.26 determined for CAR can be used in the nutritional risk assessment in patients with COPD.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] C-reactive protein levels in patients with chronic obstructive pulmonary disease and asthma
    Urboniene, Daiva
    Sakalauskas, Raimundas
    Sitkauskiene, Brigita
    MEDICINA-LITHUANIA, 2008, 44 (11): : 833 - 840
  • [22] Prognostic value of the C-reactive protein-to-albumin ratio in patients with infective endocarditis
    Baykiz, D.
    Govdeli, E. A.
    Demirtakan, Z. G.
    Elitok, A.
    Umman, B.
    Bugra, Z.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (23) : 8728 - 8737
  • [23] Comparison of C-reactive protein and C-reactive protein-to-albumin ratio in predicting mortality among geriatric coronavirus disease 2019 patients
    Ak, Rohat
    Doganay, Fatih
    Yilmaz, Erdal
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2022, 68 (01): : 82 - 86
  • [24] Effect of nutritional risk on cognitive function in patients with chronic obstructive pulmonary disease
    Huang, Yiben
    Ma, Jiedong
    Jiang, Bingqian
    Yang, Naiping
    Fu, Fangyi
    Chen, Xianjing
    Liu, Chunyan
    Miao, Xiaqi
    Mao, Huanhuan
    Zheng, Rongrong
    Wang, Jianing
    Ding, Keke
    Zhang, Xiaodiao
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (02)
  • [25] Comparison of C-reactive Protein Levels in Patients With Lung Cancer and Chronic Obstructive Pulmonary Disease
    Vaguliene, Neringa
    Zemaitis, Marius
    Miliauskas, Skaidrius
    Urboniene, Daiva
    Sitkauskiene, Brigita
    Sakalauskas, Raimundas
    MEDICINA-LITHUANIA, 2011, 47 (08): : 421 - 427
  • [26] C-Reactive Protein Levels Predict Bacterial Exacerbation in Patients With Chronic Obstructive Pulmonary Disease
    Peng, Chunhong
    Tian, Chan
    Zhang, Yonggang
    Yang, Xiaodong
    Feng, Yulin
    Fan, Hong
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2013, 345 (03) : 190 - 194
  • [27] A New Mortality Predictor in Patients of Internal Medicine Intensive Care Unit: C-Reactive Protein-to-Albumin Ratio
    Findikli, Huseyin Avni
    Erdogan, Murat
    Sahin Tutak, Ayse
    JOURNAL OF CRITICAL & INTENSIVE CARE, 2020, 11 (03): : 55 - 59
  • [28] C-Reactive Protein Levels, Haplotypes, and the Risk of Incident Chronic Obstructive Pulmonary Disease
    van Durme, Yannick M. T. A.
    Verhamme, Katia M. C.
    Aarnoudse, Albert-Jan L. H. J.
    Van Pottelberge, Geert R.
    Hofman, Albert
    Witteman, Jacqueline C. M.
    Joos, Guy F.
    Brusselle, Guy G.
    Stricker, Bruno H. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179 (05) : 375 - 382
  • [29] C-reactive protein levels in patients with chronic obstructive pulmonary disease: Role of infection
    Bircan, Ahmet
    Gokirmak, Munire
    Kilic, Ozkan
    Ozturk, Onder
    Akkaya, Ahmet
    MEDICAL PRINCIPLES AND PRACTICE, 2008, 17 (03) : 202 - 208
  • [30] Pretransplantation Inflammatory and Nutritional Status in Elderly Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Value of C-Reactive Protein-to-Albumin Ratio
    Miyazaki, Takuya
    Tachibana, Takayoshi
    Suzuki, Taisei
    Izumi, Akihiko
    Fujimaki, Katsumichi
    Sato, Shuku
    Tamai, Yotaro
    Michishita, Yusuke
    Suzuki, Takahiro
    Ishii, Ryuji
    Hirasawa, Akira
    Hashimoto, Chizuko
    Kabasawa, Nobuyuki
    Inoue, Yasuyuki
    Ishiyama, Taijiro
    Yamamoto, Koh
    Kanamori, Heiwa
    Tanaka, Masatsugu
    Nakajima, Hideaki
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (04): : 400e1 - 400e9